CTNNB1 and endometrial cancer: A study using 245 endometrial cancer patient samples by Kurnit et al. demonstrated that mutational analysis of CTNNB1 gene could be helpful in the identification of low-grade, early-stage endometrial cancer patients with a higher risk of recurrence [80].